Evidence map›Paper›PMID 41675882›Full record

ArticleAnnals of medicine and surgery (2012)2026

Long-term safety and effectiveness of hybrid coronary revascularization compared to conventional revascularization strategies: a systematic review and meta-analysis.

Singam Shashank, Rashmikaa Netyam, Chiranjeevee R Saravanan, Nikhil D Kolanu, Nanditha Karra, Harshada S Keluskar, Ziad Helaly, Mohammed H Albitar, Abdullah Sharbek, Seba Albitar and 3 more

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Singam ShashankGeneral Medicine, Hampshire Hospitals, NHS Foundation Trust, Basingstoke, UK.
Rashmikaa NetyamGeneral Medicine, Hampshire Hospitals, NHS Foundation Trust, Basingstoke, UK.
Chiranjeevee R SaravananInternal Medicine, Madras Medical College, India.
Nikhil D KolanuInternal Medicine, China Medical University, Shenyang, China.
Nanditha KarraInternal Medicine, Osmania Medical College, Hyderabad, India.
Harshada S KeluskarInternal Medicine, Kazan State Medical University, Russia.
Ziad HelalyCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Mohammed H AlbitarCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Abdullah SharbekCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Seba AlbitarCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Pugazhendi InbanInternal Medicine, St. Mary's General Hospital and Saint Clare's Health, New York.
Mohammed D M MarsoolInternal Medicine, Mayo Clinic, Scottsdale, Phoenix, Arizona.
Omniat A HussinInternal Medicine, Manhal University, Khartoum, Sudan.ORCID https://orcid.org/0000-0002-5021-263X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hybrid coronary revascularization (HCR), a combination of percutaneous coronary intervention and coronary artery bypass grafting (CABG), is an emerging treatment for patients with multivessel coronary artery disease (MVCAD). While traditional CABG is considered the standard, HCR may mitigate issues like saphenous vein graft failure. Methods: We systematically searched PubMed, Scopus, Web of Science, and Embase until September 2024, targeting randomized controlled trials (RCTs) that evaluated HCR against CABG in MVCAD patients. The quality of included studies was assessed using the ROB2 tool, and data were analyzed using RevMan 5.4. Four RCTs ( Results: Four RCTs ( Conclusion: HCR demonstrates comparable safety and effectiveness to CABG for MVCAD, with similar rates of key outcomes at both 30 days and 1 year. Further research with larger samples and longer follow-up is recommended to confirm these findings.

Indexed as

coronary artery bypasshybrid proceduresmultivessel coronary diseasemyocardial revascularizationpercutaneous coronary intervention

Identifiers

PMID41675882
PMCPMC12889239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.